FOLH1 and neoplasm: Furthermore, we observed a higher rate of cellular PSMA expression (4/25) compared to Heitkötter et al. (1/599), which may have implications for the feasibility of PSMA-RLT, as tumour cell expression could enhance treatment efficacy.